Debt Vs Equity Finance

NEWS
capital raisingMorphose Capital PartnersSME growth
By Morphose•23 July 2024
Debt Vs Equity Finance

Following the success of our series of events on scaling for growth and exit, we’re hosting some further events focusing on different types of funding mechanisms and examining at what point in the life cycle of a smaller business they might be applicable. So the next event we have lined up will explore debt finance and how to raise growth capital through debt.

The advantage of debt finance is that unlike equity finance it doesn’t involve giving away shares in the business for capital. However, as a vehicle it’s generally better suited to more established or cash generative businesses with tangible assets, so in brief, businesses that can evidence they can service the debt plus fees and interest from cash flow. If there are existing debts in the business such as BBLS or RLS, these will often have to be repaid, as it’s likely a lender will require a first charge on assets. Interest-rate wise, expect to add a 5/6 point premium on top of Libor, currently 5.25%. For a company without much collateral, plan for an additional 2/3 points since you’ll likely need to involve a specialist mezzanine debt who will be comfortable taking a position but for a higher premium return.

Debt finance can really help to fuel growth and even in today’s climate of high interest rates it can still be some of the cheapest forms of capital. Debt finance should certainly be a consideration to fund acquisitions or MBOs. Most recently, we’ve helped secure funding for a partnership buyout. In this case, it was a mature business where one partner wished to take a well-earned retirement while the other wanted to stay on in the business. We were appointed to advise on and identify the best mechanism to achieve this to satisfy both parties’ needs. The company’s strong balance sheet supported the transaction, and we were able to secure asset backed finance to achieve the partner buyout.

We also work with companies helping them use debt to finance acquisitions, in this instance we source and structure a workable finance solution to enable the acquisition to proceed. Understandably, a lender will not part with cash lightly as they need to mitigate their risk, so robust pre- and post-integration balance sheets and projections must be submitted along with full disclosure on potential liabilities. The lender will stress test projections looking at best- and worst-case scenarios and make a decision based on the level of perceived risk. From historic dealings, we’re very versed in the criteria required by banks and alternative lenders and our financial modelling and projection expertise will ensure that lenders receive the data in the format they need, thereby expediting the process. In equal measure, we operate with candour, and if we see that a lender’s criteria isn’t likely to be met we advise early on.

If you’re interested in debt finance and would like to find out more or attend our breakfast meeting in London on debt finance on October 3, 2024, please do get in touch.

Morphose Capital Partners Team

About Morphose Capital Partners

Morphose Capital Partners is a leading advisory firm specializing in mergers & acquisitions, corporate finance, and strategic transactions for owner-managed businesses across the UK.

With decades of combined experience, our team provides expert guidance through every stage of your business journey – from early-stage funding and growth capital to strategic exits and business sales.

We pride ourselves on building long-term relationships with our clients, offering personalized service and deep sector expertise to help you achieve your business objectives while maximizing value at every opportunity.

Related Articles

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations
NEWS
12 February 2026By Sara Lavallin

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Read More
Can The Ghost of CGT Past Forecast What's to Come?
NEWS
3 November 2025By Elena Balsera

Can The Ghost of CGT Past Forecast What's to Come?

Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Read More
Introducing Dr Tom McColm
NEWS
3 November 2025By Elena Balsera

Introducing Dr Tom McColm

Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.

Read More